The seropositivities against atypical pneumonia agents in patients with community-acquired pneumonia;Toplum kökenli̇ pnömoni̇ tanisi alan hastalarda ati̇pi̇k pnömoni̇ etkenlerine karşi seropozi̇ti̇ fli̇ǧin araştirilmasi

Mikrobiyoloji Bulteni

Volumn 37, Issue 4, 2003, Pages 247-253

  Sayan, Murat ^a   Kilinç, Oǧuz ^a   Yüce, Ayşe ^a   Uçan, Eyüp Sabri ^a   Genç, Sabahat ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Atypical pneumonia; Indirect immunofluorescent assay; Seroprevalence

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADENOVIRUS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; CONFERENCE PAPER; COXIELLA BURNETII; EPIDEMIOLOGICAL DATA; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LEGIONELLA PNEUMOPHILA; MYCOPLASMA PNEUMONIAE; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PREVALENCE; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SERODIAGNOSIS; STATISTICAL ANALYSIS; TREATMENT PLANNING; ADULT; ARTICLE; BACTERIAL PNEUMONIA; BLOOD; CASE CONTROL STUDY; COMMUNICABLE DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; PARAMYXOVIRUS; VIROLOGY; VIRUS PNEUMONIA;

ADENOVIRIDAE; ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; COXIELLA BURNETII; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LEGIONELLA PNEUMOPHILA; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS;

EID: 0346501926     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Yanagihara K, Kohno S, Matsusima T: Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrobial Agents 2001, 18 (Suppl 1): S45-48.
2. Niederman MS: Community-acquired pneumonia: Defining the problem. Special Suppl Infect Med 1998, 15: 11-19.
3. Ramirez JA: Community-acquired pneumonia in adults. Prim Care 2003, 30: 155-171.
4. The British Thoracic Society: Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993, 49: 346-350.
5. Plouffe JF: Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis 2000, 31 (Suppl 2): S35-39.
6. Dalhoff K: Worldwide guidelines for respiratory tract infections: Community-acquired pneumonia. Int J Antimicrob Agents 2001, 18 (Suppl 1): S39-44.
7. Tan JS: Role of 'atypical' pneumonia pathogens in respiratory tract infections. Can Respir J 1999, 6 (Suppl A): 15A-19A.
8. Hindiyeh M, Carroll KC: Laboratory diagnosis of atypical pneumonia. Semin Respir Infect 2000, 15: 101-113.
9. Niederman MS, Bass JB Jr, Campbell GD, et al: Guidelines for the initial management of adults with community-aquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993, 148: 1418-1426.
10. Lieberman D, Lieberman D, Korsonsky I, et al: A comparative study of the etiology of adult upper and lower respiratory tract infections in the community. Diag Microbiol Infect Dis 2000, 42: 21-28.
11. Gleason PP: The emerging role of atypical pathogens in community-aquired pneumonia. Pharmacotherapy 2002, 22 (1 Pt 2): 2S-11S.
12. Skerrett SJ: Diagnostic testing to establish a microbial cause is helpful in the management of community-aquired pneumonia. Semin Respir Infect 1997, 12: 308-321.
13. Green DS, San Pedro GS: Empiric therapy of community-aquired pneumonia. Resp Infect 2000, 15: 227-233.
14. Ruiz M, Ewig S, Angeles M, et al: Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999, 160: 397-405.
15. Mulazimoǧlu L: Treatment of community-acquired pneumonia in hospitalized patients. Int J Antimicrobial Agents 2001, 18: 63-70.
16. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN: Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course. Am J Med 1996, 101: 508-515.
17. McConnell CT, Plouffe JF, Mueller CF, et al: Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. CBPIS study group. Community-based pneumonia incidence study. Radiology 1994, 192: 819-824.
18. Lim WS, Macfarlane JT, Boswell TC, et al: Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines. Thorax 2001, 56: 296-301.
19. Lee SJ, Lee MG, Jeon MJ, Jung KS, Lee HK, Kishimoto T. Atypical pathogens in adult patients admitted with community-acquired pneumonia in Korea. Jpn J Infect Dis 2002, 55: 157-159.
20. Ben-Yaakov M, Lazarovich Z, Beer S, Boldur I: Serodiagnosis of atypical respiratory infections. Harefuah 1995, 129: 229-232.
21. Dudko S, Plusa T, Chcialowski A, Bejm J, Carewicz R: Serological screening examinations of atypical pathogens (Mycoplasma pneumoniae, Chlamydia pneumoniae) in respiratory tract infection. Pol Merkuriusz Lek 2000, 7: 23-26.
22. Peeling RW, Wang SP, Graystone JT, et al: Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results. J Infect Dis 2000, 181 (Suppl 3): 426-429.